Table 3.
Analysis method | Indicators | Unstandardized coefficients | Standardized coefficients | t | P | |
---|---|---|---|---|---|---|
B | Std. error | β | ||||
Univariate analysis | ||||||
sUA/Cr | −0.033 | 0.011 | −0.204 | −3.126 | 0.002 | |
Sex | −0.112 | 0.031 | −0.230 | −3.555 | <0.001 | |
Age | 0.002 | 0.001 | 0.099 | 1.502 | 0.135 | |
BMI | −0.020 | 0.004 | −0.308 | −4.863 | <0.001 | |
Dyslipidemia | −0.114 | 0.035 | −0.214 | −3.292 | 0.001 | |
Abnormal liver function | −0.147 | 0.027 | −0.342 | −5.472 | <0.001 | |
Abdominal obesity | −0.064 | 0.041 | −0.104 | −1.576 | 0.116 | |
Hypertension | −0.028 | 0.031 | −0.059 | −0.881 | 0.379 | |
Diabetes | −0.049 | 0.057 | −0.057 | −0.853 | 0.395 | |
Smoking history | −0.050 | 0.030 | −0.112 | −1.693 | 0.092 | |
Drinking history | −0.067 | 0.029 | −0.151 | −2.289 | 0.023 | |
| ||||||
Multivariate analysis | ||||||
sUA/Cr | −0.025 | 0.010 | −0.154 | −2.439 | 0.016 | |
Sex | −0.064 | 0.033 | −0.131 | −1.914 | 0.057 | |
BMI | −0.012 | 0.004 | −0.184 | −2.892 | 0.004 | |
Dyslipidemia | −0.075 | 0.032 | −0.141 | −2.319 | 0.021 | |
Abnormal liver function | −0.101 | 0.027 | −0.236 | −3.753 | <0.001 | |
Drinking history | −0.003 | 0.029 | −0.008 | −0.117 | 0.907 |
sUA/Cr, serum uric acid to serum creatinine ratio; BMI, body mass index.